Longevity Medical
Adipose stem cell therapy, fibroblast and exosome infusions, NK cell therapy, and epigenetic clock testing with on-site cell culture
Tokyo Relife Clinic is a Ginza regenerative medicine practice built around one unusual piece of infrastructure: patient cells are harvested, cultured, quality-checked, and reinfused inside the same three-floor building. The clinic sits within the Jiyugaoka Clinic Group ecosystem, founded by CEO Yoshiaki Furuyama and clinically led by Masaki Nakao, PhD, a board-certified ophthalmologist and former Harvard research fellow. Furuyama also funds a University of Tokyo endowed chair in cellular senescence control, giving the clinic a visible research bridge alongside its patient-facing care.
Tokyo Relife starts with biological-age and blood-marker assessment, then uses regenerative protocols when the goal is cellular repair, immune support, skin regeneration, or recovery. For stem cell care, adipose tissue is collected under local anesthesia, cultured in the 6F cell-processing lab, DNA-quality-checked on Illumina iScan equipment, and administered upstairs after the culture period.
Adipose-derived stem cell infusion (130M/250M cells)
Stem cell supernatant therapy
Fibroblast therapy
Exosome IV therapy
NK cell therapy
PRP therapy
Epigenetic clock testing
Basic examination set (53 items)
Comprehensive body diagnostic (57 items)
Indole test
High-dose vitamin C
NMN
Glutathione
NAD+
Myers cocktail
Hyaluronic acid injection
Botox
Mesotherapy
Hair regeneration
Starting at
¥44,000
¥44,000 for the 53-item Basic Examination; regenerative protocols move into seven-figure JPY pricing.
Entry testing: Basic Examination is ¥44,000, the 57-item comprehensive diagnostic is ¥59,400, and epigenetic clock testing is ¥275,000. Initial consultation is ¥11,000; follow-ups are free. Regenerative care: IV infusions start at ¥27,500, exosome IV is ¥800,000, fibroblast trial treatment is ¥1,650,000, and adipose-derived stem cell infusion is ¥4,620,000 for 130M cells or ¥6,050,000 for 250M cells. Stem cell care is usually a multi-visit path with consultation, fat extraction, culture time, and infusion. Billing: all care is self-pay, tax-included in JPY, with 5%/10%/15% discounts at 3/5/8 sessions.
¥44,000
Basic Examination Set with 53 biomarkers, initial consultation ¥11,000
Who it’s for
Patients seeking baseline health assessment or biological age testing before committing to treatment
¥132,000
High-dose vitamin C, NMN, glutathione, NAD+ infusions, hyaluronic acid, Botox, exosome IV
Who it’s for
Patients seeking maintenance anti-aging treatments, IV therapy, or aesthetic procedures
¥4,620,000
Adipose-derived stem cell infusion (130M or 250M cells), fibroblast therapy, NK cell therapy
Who it’s for
Patients pursuing stem cell-based regenerative treatment for systemic rejuvenation or immune enhancement
Insurance: Self Pay
Tokyo Relife is built around regenerative medicine in Ginza, with an in-house cell-processing lab, stem cell therapy, fibroblast therapy, exosome IV, NK cell therapy, and biological-age testing.
Cell culture happens in Tokyo Relife Clinic's own laboratory on the 6th floor of the Toraya Ginza Building, attached to the clinical floors above it.
No. The clinic describes its treatments as unrestricted, self-pay care. Japanese health insurance does not apply.
The clinic lists 2 to 3 hours for intravenous treatments and about 3 hours for some injection-based visits. Cell therapy timing varies and is set during consultation.
Yes. Tokyo Relife says it can propose a schedule that reduces visit count as much as possible for patients traveling from farther away.
Treatment is available to adults over 18 after physician interview and examination. Some medical conditions may change eligibility or the treatment plan.
Founder-operator behind Tokyo Relife Clinic, Jiyugaoka Clinic Group integration, and a University of Tokyo cellular-senescence chair
Tokyo Relife Clinic
Stem cell, exosome, fibroblast, and anti-aging care from an ophthalmologist with Harvard retinal-cell research training
Tokyo Relife Clinic
Hidekazu Yamada, MD, PhD
Former President, Japan Society of Anti-Aging Medicine; Kinki University Professor Emeritus
Nobutaka Furuyama, MD
Founder and Chairman, Jiyugaoka Clinic; Kitasato University
Akira Takeda, MD, PhD
Kitasato University Emeritus Professor
Directory listings are for informational purposes only. Inclusion does not constitute endorsement. Verify credentials and qualifications independently.